Multifunctional Human Bifidobacteria Strains

Natural Inhabitants of the Human Gut

The unique probiotic strains Bifidobacterium longum subsp. longum BB536, Bifidobacterium breve M-16V, Bifidobacterium longum subsp. infantis M-63, and Bifidobacterium breve B-3 are developed for the maintenance of health and well-being, not only for the adult body but also for infants. Furthermore, the effect of the gut bacteria has also been confirmed by numerous clinically proven studies. Due to their wide range of functionalities and high nutritional value, the probiotic strains are ideal for a broad spectrum of both nutrition and food applications, like infant formula, sports nutrition, food supplements and chocolate.


Key Features

• Human-Residential Bifidobacteria (HRB) (isolated from healthy infants)
• Evidence-based safety (genomic, toxicological, and clinical studies)
• Clinically proven effects (supported by scientific studies)
  [BB536: >180 studies; M-16V: >90 studies; M-63/B-3: numerous]
• Regulatory approved BB536: FDA notified GRAS status for infant formula in 2019 and for foods in 2009, Japan FOSHU status in 1996.
  M-16V: China health authorities acknowledgment for safe use in infant food in 2016, FDA notified GRAS status for foods and infant formula in 2013. 
  M-63: Self-affirmed GRAS for infant formula in 2020.
• Quality assured (FSSC22000, HACCP, HALAL, KOSHER)
• Long history of safe use in food products (for more than 40 years) (BB536/ M-16V)
• Excellent stability